MEASURING BRAIN FUNCTION,
IMPROVING CLINICAL CLARITY

Most brain health decisions are based on symptoms. Firefly brings a way to measure function directly.

WHO WE ARE

At Firefly Neuroscience, we are focused on bringing measurable brain function into everyday clinical care. Our FDA-cleared neurodiagnostic technology enables clinicians to assess how the brain is functioning, not just how a patient feels, using cognitive electrophysiology that combines quantitative EEG (qEEG) and event-related potentials (ERP) in a single, clinic-ready system.

 

This changes how care is delivered. Clinicians can identify patterns earlier, differentiate conditions when symptoms overlap, and make more informed decisions at the start of care. Instead of relying on trial and error, they have a clearer understanding of what is happening in the brain.

 

Clinicians can identify patterns earlier, differentiate conditions when symptoms overlap, and make more informed decisions at the start of care. Instead of relying on trial and error, they have a clearer understanding of what is happening in the brain.

 

Firefly is used across neurology, psychiatry, TMS, and cognitive care settings to support conditions such as concussion, cognitive decline, depression, anxiety, ADHD, and other brain-based disorders. It helps clinicians establish a baseline, guide treatment selection, and monitor how brain function changes over time, enabling more personalized and data-informed care.

 

Our platform is built on one of the largest proprietary normative EEG and ERP databases, with over 191,000 recorded sessions. This allows clinicians to evaluate each patient against age-matched patterns and track progress longitudinally.

 

Firefly exists to close the gap between symptoms and brain function, helping clinicians diagnose earlier, tailor treatment more precisely, and better understand how patients are progressing throughout care.

MISSION

Through AI, we innovatively harness the power of data to amplify clinical insight and enable greater precision in neurological care.

VISION

To redefine the standard of care for those navigating cognitive disorders.

Our Values

To consistently achieve responsible clinical-grade innovation, we uphold three grounding values, while embracing three that propel our forward-thinking:

Integrity:

We prioritize the trust and security of our colleagues, customers and patients — upholding ethical standards and ensuring our initiatives follow industry regulations including privacy guidelines and data protection measures.

Accountability:

We believe in taking ownership of our actions, decisions, and outcomes. By fostering a culture focused on patient-centricity and responsibility, we honor our commitments to our teammates and customers, building trust and setting the standard for excellence.

Precision:

Our elevated, clinical-grade standards and meticulous attention to detail are the cornerstone of our success, fostering a sense of passion, purpose and pride in our work.

Objectivity:

We’re data-driven, not opinion-led, and we believe operating this way creates an inclusive environment where all stakeholders can collaborate with confidence and be bold and courageous in driving advancements.

Innovation:

We’re dedicated to building and deploying groundbreaking solutions that are purpose-built to redefine the standard of care and empower those navigating brain health conditions with a clearer path to improved outcomes.

Agility:

We have an unwavering commitment to creating and positively responding to change–bringing an openness to fresh ideas, having a willingness to explore new possibilities and an eagerness to test and learn in an ever-evolving environment.

Our Leadership

OUR LEADERSHIP

Discover the dedicated team of experts leading Firefly Neuroscience to the forefront of brain health technology.

LEARN MORE

WHY WE'RE LEADING THE FIELD

By bringing a direct measure of brain function into the process, we are helping shift care from interpretation alone to a more complete view that includes how the brain is actually functioning. This allows clinicians to move earlier, act with greater confidence, and tailor care to the individual rather than relying on generalized pathways.

 

As this approach becomes more integrated into neurology, psychiatry, TMS, and cognitive care, it has the potential to change how brain-based conditions are identified, managed, and followed over time.

JOIN THE FIREFLY TEAM, REVOLUTIONIZING BRAIN HEALTH

We’re on a mission to transform neurological care, and we need passionate individuals to join us. If you’re driven to make a real impact and thrive in a dynamic environment, explore our openings and be part of shaping the future of healthcare.

LEARN MORE

CONTACT US

Contact Firefly Neuroscience to learn more about BNA™ or schedule a product demo. We’re here to assist and provide 
you with the information you need to make the best decision 
for your practice.

LET'S TALK

FAQs

Who is Firefly Neuroscience, and what do they do?

Firefly Neuroscience develops FDA-cleared neurodiagnostic devices that help clinicians measure and track brain function using qEEG and ERP.

 

The technology is used to support earlier insight, more informed treatment decisions, and a clearer understanding of patient progress across a range of neurological and behavioral conditions.

How does BNA™ work?

BNA™ is an advanced technology developed by Firefly Neuroscience that utilizes artificial intelligence and a proprietary database to analyze electroencephalogram (EEG) data. The technology compares patients’ EEG readings at rest and during activity to normative data, identifying unique brain patterns and deviations to assist in brain health evaluation and clinical decision making.

Can Firefly Neuro technology help with all types of neurological disorders?

Firefly Neuro technology is designed to support the assessment of brain function across a wide range of neurological and behavioral conditions, but it is not intended to diagnose every disorder on its own.

 

The platform provides measurable data on brain activity and cognitive response that clinicians can evaluate alongside clinical history, symptoms, and other assessments. It is commonly used in areas such as concussion and traumatic brain injury, cognitive decline, depression, anxiety, ADHD, and other brain-based conditions.

 

Firefly is best used as part of a comprehensive clinical evaluation to help inform diagnosis, guide treatment decisions, and monitor changes in brain function over time.

Is the Evoke system safe and FDA-cleared?

Yes. The Evoke system is an FDA-cleared Class II neurodiagnostic device (510(k)) used to assess brain function using cognitive electrophysiology.

 

It is non-invasive and does not require medication, sedation, or any electrical stimulation. The assessment involves placing EEG sensors on the scalp to record the brain’s natural electrical activity while the patient completes simple auditory and visual tasks in a clinical setting.

How can I learn more about career opportunities at Firefly Neuroscience?

We’re always looking for talented individuals to join our team. Explore our Careers page to view current job openings and learn more about what it’s like to work at Firefly Neuroscience.